Back to search

Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy

Data up to Jan 2025

Published1996
Citations179
References41

Total Citations Per Year

Abstract

References (41)

Maternal serum screening for Down's syndrome in early pregnancy.

1988 • 972 citations

An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities

1984 • 743 citations

Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities

1987 • 474 citations

Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers

1992 • 467 citations

Detection of dimeric inhibin throughout the human menstrual cycle by two‐site enzyme immunoassay

1994 • 380 citations

Isolation of porcine follicular fluid inhibin of 32K daltons

1985 • 327 citations

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome

1988 • 305 citations

Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.

1992 • 294 citations

Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin

1990 • 217 citations

Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome

1988 • 193 citations

Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers

1992 • 192 citations

Immunoreactive Inhibinα-Subunit in Human Serum: Implications for Radioimmunoassay*

1990 • 168 citations

The Mathematical Basis of Multivariate Risk Screening: With Special Reference to Screening for Down's Syndrome Associated Pregnancy

1990 • 157 citations

Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome

1991 • 138 citations

Immunoassays for inhibin and its subunits Further applications of the synthetic peptide approach

1993 • 136 citations

Second‐trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome

1992 • 118 citations

Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age

1991 • 104 citations

Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme

1994 • 98 citations

First‐trimester free beta (hCG) screening for Down syndrome

1993 • 87 citations

First‐trimester maternal serum biochemical indicators in Down syndrome

1990 • 84 citations

Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.

1993 • 80 citations

Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropin

1992 • 79 citations

First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects

1993 • 77 citations

First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A

1994 • 76 citations

Evaluation of maternal serum dimeric inhibin a as a first‐trimester marker of down's syndrome

1995 • 66 citations

Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndrome

1994 • 64 citations

THE MATERNAL OVARY IS NOT THE SOURCE OF CIRCULATING INHIBIN LEVELS DURING HUMAN PREGNANCY

1987 • 64 citations

Elevated Levels of Maternal Serum Inhibin Immunoreactivity in Second Trimester Pregnancies Affected by Down's Syndrome

1993 • 59 citations

Inhibin forms in human plasma

1995 • 53 citations

Second‐trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay

1993 • 48 citations

Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker.

1993 • 48 citations

Maternal serum inhibin levels in second‐trimester down's syndrome pregnancies

1994 • 42 citations

Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of Scotland

1994 • 39 citations

The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy

1993 • 34 citations

Circulating Bioactive Inhibin Levels during Human Pregnancy

1991 • 34 citations

Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha fetoprotein and age: A retrospective study of 142 pregnancies

1991 • 33 citations

Free β-Chorionic Gonadotropin: A Cross-Reactivity Study of Two Immunometric Assays Used in Prenatal Maternal Serum Screening for Down's Syndrome

1993 • 28 citations

First‐trimester maternal serum schwangerschafts protein 1 (SP1) in pregnancies associated with chromosomal anomalies

1993 • 24 citations

Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome

1994 • 22 citations

First-trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis.

1994 • 22 citations

Variation in the levels of pregnancy‐ specific β‐1‐glycoprotein in maternal serum from chromosomally abnormal pregnancies

1992 • 20 citations

Cited By (0)

Loading...